FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

764310005: Product containing pembrolizumab in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3711221014 Product containing pembrolizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3711222019 Pembrolizumab-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647588015 Product containing pembrolizumab in parenteral dosage form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647589011 Product containing pembrolizumab in parenteral dosage form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3647590019 Pembrolizumab in parenteral dosage form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3711221014 Product containing pembrolizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3711222019 Pembrolizumab-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5502461000241113 produit contenant du pembrolizumab sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5502461000241113 produit contenant du pembrolizumab sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pembrolizumab-containing product in parenteral dose form Is a Product manufactured as parenteral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Pembrolizumab-containing product in parenteral dose form Is a Pembrolizumab-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Pembrolizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pembrolizumab true Inferred relationship Existential restriction modifier (core metadata concept) 1
Pembrolizumab-containing product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Pembrolizumab-containing product in parenteral dose form Plays role Antineoplastic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only pembrolizumab in parenteral dose form (medicinal product form) Is a True Pembrolizumab-containing product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start